Bioverativ, Bicycle Therapeutics to develop therapies for hemophilia and sickle cell disease Read more
Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative New Tuberculosis Treatments Read more
Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development Read more